Name: Tirzepatide

CAS Registry number: 2023788-19-2 Sequence: Tyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Aib-Leu-Asp-Lys-Ile-Ala-Gln-Lys(C20 diacid-γ-Glu-(AEEA)2)-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 Molecular Formula: C???H???N??O?? Molecular Weight: 4813.45 Da Purity: ≥99% (by HPLC) Appearance: White lyophilized powder Packing: 10 vials/box Product Group: Peptide

Storage Conditions: Store at -20℃ in a dry, dark place; avoid repeated freeze-thaw cycles.

Brief Introduction:

Tirzepatide is a synthetic long-acting dual GIP/GLP-1 receptor agonist peptide for laboratory research only. Modified with C20 fatty diacid side chain to bind albumin and extend circulation half-life. It activates both GIP and GLP-1 receptors synergistically, widely studied for blood glucose regulation, fat metabolism, weight management, cardiovascular protection and chronic inflammation related research.

1. Type 2 diabetes & glycemic control research: Used in cell and animal models to study glucose-dependent insulin secretion, glucagon inhibition, insulin resistance improvement and pancreatic β-cell protection mechanisms.
2. Obesity and lipid metabolism research: Applied to explore central appetite suppression, delayed gastric emptying, visceral fat reduction and brown adipose tissue thermogenesis activation.
3. Cardiovascular and metabolic complication research: Suitable for studying endothelial protection, anti-atherosclerosis, lipid lowering and systemic anti-inflammatory effects.
4. Multi-organ metabolic signaling research: For investigating dual GIP/GLP-1 mediated signal pathways in pancreas, liver, fat tissue and central nervous system.

Note:

This product is for laboratory research use only. It is not intended for human or animal therapeutic use, clinical trials, or any form of in vivo administration without prior ethical approval and regulatory authorization.